Carolina Maciel Camargo

Carolina Maciel Camargo

Auto-generated profile, based on publicly available information

Carolina Maciel Camargo

University of California, Santa Barbara

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Review of Scientific Instruments
Verified
Journal Article
Closed access
ZZZongren Zhang
Zongren Zhang
TMTjitse Van der Molen
Tjitse Van der Molen
CCCarolina Maciel Camargo
Carolina Maciel Camargo
MMMarkus W. Merk
Markus W. Merk
MKMookwang Kwon
Mookwang Kwon
PHPaul Hansma
Paul Hansma
We present a custom recording platform that enables electrophysiological recordings with Neuropixels 2.0 from human brain and heart organoids by maintaining a stable, physiological environment of 5% CO2, 37 °C, and 95% relative humidity. The platform combines a modular positioning system with real-time camera guidance for precise probe alignment. We validated the system by recording consistent bursting activity in brain organoids over a 110-min period and in heart organoids for up to 11 h.

2 December 2025 in bioRxiv
Verified
Preprint
Open access
CCCarolina M. Camargo
Carolina M. Camargo
MAMaria Camila Almeida
Maria Camila Almeida
BMBárbara Mejía-Cupajita
Bárbara Mejía-Cupajita
IHInyoung Hwang
Inyoung Hwang
MFMohamed A. Faynus
Mohamed A. Faynus
KKKenneth S. Kosik
Kenneth S. Kosik
Loss-of-function mutations in the granulin ( GRN ) gene cause frontotemporal dementia when the mutations are heterozygous and neuronal ceroid lipofuscinosis, a lysosomal storage disease, when homozygous. While it is well established that disease-causing GRN mutations decrease progranulin (PGRN) levels, leading to neurodegeneration, the cellular and molecular mechanisms underlying these conditions remain poorly understood. In this study, we utilized human induced pluripotent stem cell (iPSC) derived forebrain organoids to investigate the impact of PGRN homozygous deficiency on neuronal and glial cell populations. Through single-cell RNA sequencing, we identified robust downregulation of the mitochondrial oxidative phosphorylation pathway in PGRN KO organoids. In line with these results, PGRN KO organoids showed decreased mitochondrial respiration. Furthermore, our study demonstrated that PGRN loss induced increased levels of reactive oxygen species (ROS), lipid peroxidation and iron accumulation. Finally, we observed increased vulnerability to ferroptotic cell death in PGRN KO organoids. Our findings suggest that mitochondrial dysfunction and impaired responses to oxidative stress are early manifestations of PGRN loss, and offer insights into the molecular mechanisms driving neurodegeneration caused by PGRN deficiency. Abstract Figure: Graphical Abstract Proposed molecular mechanisms that lead to ferroptosis of PGRN KO cells. Created with BioRender.com .:

10 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ANArina A Nikitina
Arina A Nikitina
CBChristian Bustamante
Christian Bustamante
RGRaymond Gifford
Raymond Gifford
CCCarolina M Camargo
Carolina M Camargo
BMBarbara Mejía-Cupajita
Barbara Mejía-Cupajita
KKKenneth S. Kosik
Kenneth S. Kosik
Ketamine’s rapid neuropsychiatric actions emerge from interactions that span receptors, cells, and circuits, but their net effects on human neuronal population dynamics remain incompletely defined. Here we combine human dorsal forebrain organoids with high-density microelectrode arrays (MEAs) to quantify ketamine’s effects from spikes to networks. In 6-month-old organoids, acute ketamine (20□μg/mL) abolished population bursting while neuronal firing continued mostly unchanged. Spike sorting revealed that mean firing rates declined but not silenced after ketamine Reductions were concentrated within a subset of burst-driver units previously defined as “backbone”. Functional connectivity, estimated with the spike time tiling coefficient (STTC), decreased globally after ketamine. Backbone units displayed elevated connectivity at baseline but were functionally disconnected by ketamine. Graph construction from STTC uncovered widespread network reconfiguration, characterized by redistribution of edges from backbone to non-backbone units leading to loss of hubs and less-interconnected communities. Re-exposure after chronic ketamine treatment no longer silenced population bursting, indicating tolerance. Together, these results show that ketamine acutely silences human organoid networks by disconnecting backbone units, while chronic exposure induces tolerance to re-silencing while reducing the number of backbone units and leaving the network less active and less connected. The organoid-MEA platform provides a scalable, human-relevant system for dissecting circuit-level drug effects.

27 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMaria Almeida
Maria Almeida
TWTian Wang
Tian Wang
ALAndrew P. Longhini
Andrew P. Longhini
SLSamuel Lobo
Samuel Lobo
CCCarolina Maciel Camargo
Carolina Maciel Camargo
DCDaniel C. Carrettiero
Daniel C. Carrettiero
Protein aggregation, impaired degradation, and immune activation are central hallmarks of neurodegenerative diseases, yet how these processes are coordinated remains unclear. Here, we identify Immune-Protein Degradation Bodies (I-PDBs), a previously unrecognized class of BAG2-driven, phase-separated organelles that integrate protein quality control with adaptive immunity. IFN-gamma; induce I-PDB formation at the endoplasmic reticulum (ER), where they concentrate immunoproteasome components, MHC-I peptide-loading machinery, and ER-associated chaperones. I-PDBs redirect proteostatic cargo from centrosomal aggregation pathways to spatially restricted degradation sites optimized for antigenic peptide generation, coupling selective substrate clearance to CD8+ T cell engagement. Using a cellular model of aggregation-prone tau, we show that I-PDBs capture pathological tau fibrils at ER-microtubule interfaces and process them into potentially antigenic peptides, thus reducing the load of aggregation-prone tau peptides. We term this mechanism the Proteostasis-Associated Immune Relay (PAIR), establishing I-PDBs as critical hubs linking proteostasis to immune surveillance with broad implications for disease.